Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens.

Zhang J, Valianou M, Simmons H, Robinson MK, Lee HO, Mullins SR, Marasco WA, Adams GP, Weiner LM, Cheng JD.

FASEB J. 2013 Feb;27(2):581-9. doi: 10.1096/fj.12-210377. Epub 2012 Oct 26.


FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.

Lee HO, Mullins SR, Franco-Barraza J, Valianou M, Cukierman E, Cheng JD.

BMC Cancer. 2011 Jun 13;11:245. doi: 10.1186/1471-2407-11-245.


Identification and characterization of the promoter of fibroblast activation protein.

Zhang J, Valianou M, Cheng JD.

Front Biosci (Elite Ed). 2010 Jun 1;2:1154-63.


Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins.

Castelló-Cros R, Khan DR, Simons J, Valianou M, Cukierman E.

BMC Cancer. 2009 Mar 26;9:94. doi: 10.1186/1471-2407-9-94.


Ovarian normal and tumor-associated fibroblasts retain in vivo stromal characteristics in a 3-D matrix-dependent manner.

Quiros RM, Valianou M, Kwon Y, Brown KM, Godwin AK, Cukierman E.

Gynecol Oncol. 2008 Jul;110(1):99-109. doi: 10.1016/j.ygyno.2008.03.006. Epub 2008 May 2.


Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth.

Cheng JD, Valianou M, Canutescu AA, Jaffe EK, Lee HO, Wang H, Lai JH, Bachovchin WW, Weiner LM.

Mol Cancer Ther. 2005 Mar;4(3):351-60.


Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model.

Cheng JD, Dunbrack RL Jr, Valianou M, Rogatko A, Alpaugh RK, Weiner LM.

Cancer Res. 2002 Aug 15;62(16):4767-72.


Heterogeneity of four beta-thalassemia mutations in Greece.

Valianou MG, Kouvatsi A, Hassapopoulou-Matamis H, Astrinidis A, Triantaphyllidis C.

Hemoglobin. 1999 Feb;23(1):79-82. No abstract available.


Supplemental Content

Loading ...
Support Center